Filing Details

Accession Number:
0001209191-15-049824
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-03 18:46:40
Reporting Period:
2015-06-01
Filing Date:
2015-06-03
Accepted Time:
2015-06-03 18:46:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1202094 Kimberly Manhard 123 Saginaw Drive
Redwood City CA 94063
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-01 2,708 $9.05 2,708 No 4 M Direct
Common Stock Disposition 2015-06-01 2,708 $21.17 0 No 4 S Direct
Common Stock Acquisiton 2015-06-02 10,500 $8.80 10,500 No 4 M Direct
Common Stock Disposition 2015-06-02 10,500 $23.58 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-06-01 2,708 $0.00 2,708 $9.05
Common Stock Stock Option (Right to Buy) Disposition 2015-06-02 10,500 $0.00 10,500 $8.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,292 2024-12-12 No 4 M Direct
21,000 2024-01-10 No 4 M Direct
Footnotes
  1. The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the date of grant (12/12/2014).
  2. The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (01/10/2014).